Catalog

Record Details

Catalog Search



Drugs for life : how pharmaceutical companies define our health / Joseph Dumit.

Dumit, Joseph (Author).
Image of item

Available copies

  • 1 of 1 copy available at Evergreen Indiana.

Current holds

0 current holds with 1 total copy.

Series Information

Experimental futures
Location Call Number / Copy Notes Barcode Shelving Location Status Due Date
Jefferson Co PL - Madison Main Branch 338.4761 DUM (Text) 39391006475444 Nonfiction Available -

Record details

  • ISBN: 9780822348603 (cloth : alk. paper)
  • ISBN: 0822348608 (cloth : alk. paper)
  • ISBN: 9780822348719 (pbk. : alk. paper)
  • ISBN: 0822348713 (pbk. : alk. paper)
  • Physical Description: xii, 262 pages : illustrations ; 24 cm.
  • Publisher: Durham, NC : Duke University Press, 2012.

Content descriptions

Bibliography, etc. Note:
Includes bibliographical references (pages [219]-256) and index.
Formatted Contents Note:
Responding to facts -- Pharmaceutical witnessing and direct-to-consumer advertising -- Having to grow medicine -- Mass health : illness is a line you cross -- Moving the lines : deciding on thresholds -- Knowing your numbers : pharmaceutical lifestyles -- Living in a world of surplus health: frequently asked questions.
Summary, etc.:
"Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs."--Provided by publisher.
Subject: Pharmaceutical industry > Social aspects > United States.
Drugs > Social aspects > United States.
Drug utilization > United States.
Drug Industry > United States.
Consumer Participation > United States.
Social Environment > United States.

Additional Resources